Celon Pharma’s pill shows promise in reducing dyskinesia in Parkinson’s trial
HQ Team March 17, 2025: Celon Pharma’s human trial with PDE10A inhibitor, CPL’36, has achieved statistically significant reductions in involuntary movements caused by
Drugs
Research
Pharma
AstraZeneca acquires EsoBiotec for $1billion in a bid to push its cell therapy agenda
HQ Team March 17, 2025: AstraZeneca has announced plans to acquire EsoBiotec, a biotechnology company pioneering in vivo cell therapies, for up to
Drugs
Eneboparatide succeeds in Phase III trial for chronic hypoparathyroidism
HQ Team March 17, 2025: The Phase III CALYPSO trial, led by Alexion, AstraZeneca Rare Disease, has shown promising results for eneboparatide (AZP-3601),
Health
Research
MIT’s 40Hz gamma stimulation shows promise in slowing Alzheimer’s progression
HQ Team March 15, 2025: A decade of research at MIT’s Picower Institute for Learning and Memory has brought hope to millions battling
Health
Australian man becomes world’s first to leave hospital with titanium heart
HQ Team March 15, 2025: An Australian man in his forties has become the first person in the world to be discharged from
Drugs
UN narcotics agency places 6 new substances under international control
March 14, 2025 –The United Nations Commission on Narcotic Drugs (CND) has decided to place five new psychoactive substances and one medicine under
Health
FDA approves expanded use of eculizumab for pediatric myasthenia gravis
HQ Team March 13, 2025: The U.S. Food and Drug Administration (FDA) has approved the expanded use of drug eculizumab (marketed as Soliris)
Health
Limiting TV time may reduce heart disease risk in people disposed to diabetes 2
HQ Team March 13, 2025: A study published in the Journal of the American Heart Association reveals that limiting TV viewing to no more than
Pharma
Gilead’s once-yearly lenacapavir shot for HIV prevention shows strong promise
HQ Team March 12, 2025: In a significant development for HIV prevention, Gilead Sciences has unveiled promising data from its Phase 1 study
Pharma
Roche secures Zealand pharma’s obesity drug in $5.3 billion deal
HQ Team March 12, 2025: Swiss pharmaceutical giant Roche has entered into an exclusive collaboration and licensing agreement with Denmark’s Zealand Pharma to